Members of the Panel have deliberated and, unanimously, reached the following conclusions:
1. The Gent and Cologne laboratories have violated ISL 5.2.4.3.2.2;
2. Claimant, USADA, has not demonstrated to the Panel's comfortable satisfaction that this violation did not cause Ms. Jenkins' adverse analytical finding;
3. The testing results of Respondent, LaTasha Jenkins, are set aside.
AAA 2007 No. 30 190 00199 07 USADA vs Latasha Jenkins - Initial Decision
Original document
Parameters
- Legal Source
- National Decisions
- Date
- 12 December 2007
- Arbitrator
- Baker, Mark C.
- Fortier, Yves
- Shycoff, Barbara
- Original Source
- Law firm
- Country
- United States of America
- Language
- English
- ADRV
- Adverse Analytical Finding / presence
- Sport/IFs
- Athletics (WA) - World Athletics
- Other organisations
- American Arbitration Association (AAA) - North American Court of Arbitration for Sport Panel
- United States Anti-Doping Agency (USADA)
- Laboratories
- Cologne, Germany: Institute of Biochemistry - German Sport University Cologne
- Ghent, Belgium: DoCoLab Universiteit Gent-UGent
- Analytical aspects
- B sample analysis
- Testing results set aside
- Substances
- 19-norandrosterone
- Nandrolone (19-nortestosterone)
- Document type
- Pdf file
- Date generated
- 17 May 2013
- Date of last modification
- 5 December 2019
